HUNTINGTON'S DISEASE
Clinical trials for HUNTINGTON'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new HUNTINGTON'S DISEASE trials appear
Sign up with your email to follow new studies for HUNTINGTON'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Huntington's drug enters first human tests
Disease control OngoingThis early-stage study tests a new drug called RG6496 in people who carry the gene for Huntington's disease. The main goal is to check if the drug is safe and how the body handles it. About 40 participants will receive a single dose injected into the spine, with some getting a pl…
Matched conditions: HUNTINGTON'S DISEASE
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Brain gene therapy aims to silence Huntington's disease
Disease control OngoingThis early-stage trial tests a one-time gene therapy called AMT-130, injected directly into the brain, to lower the production of the harmful huntingtin protein. It involves 43 adults with early Huntington's disease. The study is primarily checking safety, but also looks for sign…
Matched conditions: HUNTINGTON'S DISEASE
Phase: PHASE1, PHASE2 • Sponsor: UniQure Biopharma B.V. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New pouch aims to make mealtimes safer for Huntington's patients
Symptom relief TerminatedThis study was designed to test whether a reusable pouch called DoddleBags could help people with Huntington's disease eat more easily and safely. The pouch holds pureed food and can be used with an anti-choking cap or spoon attachment. The trial was withdrawn before any particip…
Matched conditions: HUNTINGTON'S DISEASE
Phase: NA • Sponsor: University of Hull • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC